Chemokine receptor 9 (CCR9) polymorphisms: Susceptibility genes for inflammatory small bowel disease?

被引：0
|
作者：
McGovern, DP
Van Heel, D
Dechairo, B
Ahmad, T
Lench, N
Anderson, R
Jewell, D
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M1442
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [1] CCR9 and inflammatory bowel disease
    Koenecke, Christian
    Foerster, Reinhold
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (03) : 297 - 306
  • [2] Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease
    Zhang, Jing
    Romero, Jan
    Chan, Audrey
    Goss, Jennifer
    Stucka, Sabrina
    Cross, Jason
    Chamberlain, Brian
    Varoglu, Mustafa
    Chandonnet, Haoqun
    Ryan, Dominic
    Lippa, Blaise
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) : 3661 - 3664
  • [3] A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease
    Kalindjian, S. Barret
    Kadnur, Sanjay V.
    Hewson, Christopher A.
    Venkateshappa, Chandregowda
    Juluri, Suresh
    Kristam, Rajendra
    Kulkarni, Bheemashankar
    Mohammed, Zainuddin
    Saxena, Rohit
    Viswanadhan, Vellarkad N.
    Aiyar, Jayashree
    McVey, Donna
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3098 - 3111
  • [4] Discovery of indole inhibitors of chemokine receptor 9 (CCR9)
    Pandya, Bhaumik A.
    Baber, Christian
    Chan, Audrey
    Chamberlain, Brian
    Chandonnet, Haoqun
    Goss, Jennifer
    Hopper, Timothy
    Lippa, Blaise
    Poutsiaka, Katherine
    Romero, Jan
    Stucka, Sabrina
    Varoglu, Mustafa
    Zhang, Jing
    Zhang, Xin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3322 - 3325
  • [5] Expression of thymus expressed chemokine (TECK) and its receptor CCR9 in the small bowel: Enhanced recirculation of CCR9+lymphocytes in small bowel Crohn's disease.
    Papadakis, KA
    Prehn, J
    Andrew, DP
    Ponath, PD
    Targan, SR
    FASEB JOURNAL, 2000, 14 (06): : A975 - A975
  • [6] CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
    Wendt, Emily
    Keshav, Satish
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2015, 8 : 119 - 130
  • [7] Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
    Walters, Matthew J.
    Wang, Yu
    Lai, Nu
    Baumgart, Trageen
    Zhao, Bin N.
    Dairaghi, Daniel J.
    Bekker, Pirow
    Ertl, Linda S.
    Penfold, Mark E. T.
    Jaen, Juan C.
    Keshav, Satish
    Wendt, Emily
    Pennell, Andrew
    Ungashe, Solomon
    Wei, Zheng
    Wright, J. J. Kim
    Schall, Thomas J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01): : 61 - 69
  • [8] Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine
    Pabst, O
    Ohl, L
    Wendland, M
    Wurbel, MA
    Kremmer, E
    Malissen, B
    Förster, R
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (03): : 411 - 416
  • [9] Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel
    Hwang, ST
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : XIV - XV
  • [10] Regional expression of thymus expressed chemokine (TECK) and its receptor CCR9 in the small bowel: Evidence for enhanced recirculation of CCR9+lymphocytes in small bowel Crohn's disease.
    Papadakis, KA
    Prehn, JL
    Andrew, DP
    Ponath, PD
    Targan, SR
    GASTROENTEROLOGY, 2000, 118 (04) : A663 - A663
12345